<DOC>
	<DOCNO>NCT01625481</DOCNO>
	<brief_summary>The purpose study assess safety performance Seal-V adjunct standard surgical procedure achieve hemostasis patient undergoing peripheral vascular reconstruction surgery use synthetic graft .</brief_summary>
	<brief_title>Seal-V Safety Performance Study</brief_title>
	<detailed_description />
	<criteria>Male female &gt; 18 year age Signed Informed Consent Patients require vascular reconstruction surgery use synthetic ( PTFE , Dacron ) autologous ( native vein ) graft , include follow : Peripheral bypass surgery , arterioarterial bypass [ include : axillo ( bi ) femoral , ilio ( bi ) femoral , femorofemoral , iliopopliteal , femoropopliteal ( include knee ) , femorotibial vessel bypass ] Arteriovenous ( AV ) dialysis access shunt upper low extremity Patients able willing complete followup visit Vascular surgery peripheral bypass surgery arteriovenous ( AV ) dialysis access shunt procedure describe Reoperation treatment site Known sensitivity device material , indigo carmine dye alginate Pregnant lactate woman Systemic infection Participation another clinical trial treatment investigational agent past 30 day Congenital coagulation disorder ( e.g. , thrombocytopenia [ &lt; 100,000 platelet count ] , thromboasthenia , hemophilia , von Willebrand disease ) Severe congenital acquire immunodeficiency ( e.g. , HIV infection long term treatment immunosuppressive drug ) Prior radiation therapy operate field Intraoperative Major intraoperative complication require resuscitation deviation plan surgical procedure Intraoperative change plan surgical procedure result patient long meet preoperative inclusion and/or exclusion criterion Local infection operate field</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>